NCT02552979

Brief Summary

Positive reactions in atopy patch test in children with atopic dermatitis.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2012

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

September 16, 2015

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 17, 2015

Completed
Last Updated

May 3, 2016

Status Verified

May 1, 2016

Enrollment Period

2.9 years

First QC Date

September 16, 2015

Last Update Submit

May 2, 2016

Conditions

Atopic DermatitisFood Allergy

Keywords

atopic dermatitisatopic patch test

Outcome Measures

Primary Outcomes (1)

  • atopic patch test in atopic dermatitis children

    1 year

Interventions

atopic patch testOTHER

Eligibility Criteria

Age1 Month - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

children with atopic dermatitis

You may qualify if:

  • Patients who had history of atopic dermatitis

You may not qualify if:

  • Who have dermographism
  • Who have chronic disease eg. autoimmune disease, immune deficiency, cancer or allergic disease
  • Pregnant women
  • Who receive antihistamine, topical steroid and systemic steroid \> 20 mg/day within 7 days prior study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Dermatitis, AtopicFood Hypersensitivity

Condition Hierarchy (Ancestors)

Skin Diseases, GeneticGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesDermatitisSkin DiseasesSkin and Connective Tissue DiseasesSkin Diseases, EczematousHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 16, 2015

First Posted

September 17, 2015

Study Start

January 1, 2012

Primary Completion

December 1, 2014

Study Completion

September 1, 2015

Last Updated

May 3, 2016

Record last verified: 2016-05